Publication
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level
A Mega-analysis of Individual Participant-Level Data
Kate Merritt, Philip K. McGuire, Alice Egerton, André Aleman, Wolfgang Block, Oswald J. N. Bloemen, Faith Borgan, Juan R. Bustillo, Aristides A. Capizzano, Jennifer Marie Coughlin, Camilo De la Fuente-Sandoval, Arsime Demjaha, Kara Dempster, Kim Q. Do, Fei Du, Peter Falkai, Beata Galinska-Skok, Jurgen Gallinat, Charles Gasparovic, Cedric E. Ginestet, Naoki Goto, Ariel Graff-Guerrero, Beng Choon Ho, Oliver D. Howes, Sameer Jauhar, Peter Jeon, Tadafumi Kato, Charles A. Kaufmann, Lawrence S. Kegeles, Matcheri Keshavan, Sang-Young Kim, Hiroshi Kunugi, John Lauriello, Edith Jantine Liemburg, Meghan E. Mcilwain, Gemma Modinos, Elias D. Mouchlianitis, Jun Nakamura, Igor Nenadic, Dost Öngür, Miho Ota, Lena Palaniyappan, Christos Pantelis, Eric Plitman, Sotirios Posporelis, Scot E. Purdon, Jürgen R. Reichenbach, Perry F. Renshaw, Bruce R. Russell, Akira Sawa, Martin Schaefer, Dikoma C. Shungu, Stefan Smesny, Jeffrey A. Stanley, James M. Stone, Agata Szulc, Reggie Taylor, Katy Thakkar, Jean Théberge, Philip G. Tibbo, Therese van Amelsvoort, Jerzy Walecki, Peter C. Williamson, Stephen James Wood, Lijing Xin, Hidenori Yamasue
JAMA Psychiatry, June 2021, American Medical Association (AMA)
DOI: 10.1001/jamapsychiatry.2021.0380